Kabipem 500mg Injection

About

Kabipem 500mg Injection contains Pemetrexed, an advanced antifolate antineoplastic agent specifically designed for the treatment of certain cancers, most notably non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. Its mechanism of action involves the inhibition of several key enzymes that are critical for folate metabolism and pyrimidine synthesis within cancer cells. By disrupting these vital biochemical pathways, Pemetrexed effectively interferes with DNA replication and repair processes, ultimately leading to the cessation of cancer cell proliferation and inducing cell death in rapidly dividing malignant tissues.

This medication is typically administered intravenously, often as part of a combination therapy regimen with other chemotherapy drugs, to maximize its therapeutic efficacy. A crucial aspect of Pemetrexed treatment involves mandatory vitamin supplementation with folic acid and vitamin B12. This pre-medication strategy is essential to mitigate and manage potential toxicities associated with the drug, ensuring a safer and more tolerable treatment experience for patients while maintaining its potent anti-cancer effects.

Uses

• Non-small cell lung cancer (NSCLC)
• Malignant pleural mesothelioma
• Maintenance therapy for NSCLC
• Advanced or metastatic NSCLC

Directions For Use

Administer intravenously under the supervision of an oncologist. Pre-medication with folic acid and vitamin B12 is crucial.

Benefits

• Effective in treating specific types of lung cancer and mesothelioma.
• Can improve progression-free and overall survival.
• Offers a targeted approach to disrupt cancer cell growth.
• Often used in combination with platinum-based agents for enhanced efficacy.
• Provides a valuable treatment option for challenging malignancies.
• Can lead to significant tumor response and disease stabilization.

Side Effects

• Myelosuppression (neutropenia, thrombocytopenia, anemia)
• Nausea and vomiting
• Fatigue
• Diarrhea
• Mucositis/stomatitis
• Skin rash
• Anorexia
• Peripheral neuropathy
• Elevated liver enzymes
• Kidney dysfunction
• Infection risk
• Constipation

Safety Measures

• Alcohol - Avoid alcohol during treatment as it may exacerbate side effects like nausea or liver toxicity.
• Pregnancy - Contraindicated in pregnancy due to severe fetal harm risk. Effective contraception is essential during and after treatment.
• Breastfeeding - Not recommended during breastfeeding due to potential harm to the infant.
• Liver - Use with caution in patients with pre-existing liver impairment; dose adjustments may be necessary.
• Kidney - Dose adjustment is required for patients with renal impairment due to its renal excretion.
• Lung - Monitor for pulmonary toxicity, including interstitial lung disease, though rare. Report any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.